Global Leading Market Research Publisher QYResearch announces the release of its latest report “Feed β-Glucanase – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Feed β-Glucanase market, including market size, share, demand, industry development status, and forecasts for the next few years.
For animal nutritionists, feed formulators, and integrated livestock producers, the challenge of maximizing nutrient utilization from cereal-based diets is both economic and technical. Cereal grains—barley, wheat, oats—contain β-glucans, non-starch polysaccharides that increase digesta viscosity in monogastric animals, reducing nutrient absorption and depressing growth performance. Feed β-glucanase addresses this challenge directly. As an exogenous enzyme produced through fungal or bacterial fermentation, β-glucanase specifically degrades β-glucans in feed ingredients, neutralizing their anti-nutritional effects and improving the bioavailability of energy and protein. The result is enhanced feed conversion, reduced variability in animal performance, and greater flexibility in ingredient selection. The global market, valued at US$45.83 million in 2025 and projected to reach US$75.21 million by 2032 at a CAGR of 7.4%, reflects increasing adoption of enzyme technologies across poultry, swine, and aquaculture production. For industry strategists and investors, understanding enzyme sources, application-specific efficacy, and formulation strategies is essential to navigating this growing segment of the animal nutrition industry.
[Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)]
https://www.qyresearch.com/reports/6098209/feed—-glucanase
Market Size, Structure, and the Enzyme Technology Value Proposition
The US$45.8 million market valuation in 2025 corresponds to approximately 7,120 tons of global production, with average pricing around US$6,010 per ton reflecting the significant value added through fermentation and formulation. The projected 7.4% CAGR to 2032 outpaces broader feed additive markets, driven by increasing pressure on feed costs, growing awareness of enzyme benefits, and expansion of intensive livestock production.
Feed β-glucanase functions by hydrolyzing β-glucans—linear polysaccharides composed of glucose units with mixed glycosidic linkages—that form viscous solutions in the animal digestive tract. This viscosity reduces the diffusion of digestive enzymes and bile salts, interferes with nutrient absorption at the intestinal wall, and promotes proliferation of harmful bacteria. Enzyme addition reduces digesta viscosity, enabling more complete digestion of all dietary components, not just those directly targeted by the enzyme.
Key Industry Trends Driving Market Expansion
Several powerful currents are propelling the feed β-glucanase market forward, creating distinct strategic opportunities for enzyme manufacturers and feed producers.
1. Feed Cost Volatility and Ingredient Flexibility
Global grain markets experience significant price volatility driven by weather, trade policy, and energy costs. Livestock producers managing narrow margins seek flexibility to substitute ingredients based on relative pricing without sacrificing animal performance.
β-glucanase enables greater use of cost-effective cereals—barley, wheat, oats—in diets for poultry and swine that traditionally rely on corn and soybean meal. By neutralizing the anti-nutritional effects of β-glucans, the enzyme expands the range of ingredients that can be included in least-cost formulations. This flexibility has particular value in regions where corn is expensive or imported.
2. Antibiotic Reduction and Gut Health Focus
Regulatory restrictions on antibiotic growth promoters and consumer demand for reduced antibiotic use in livestock production have focused attention on gut health management. Viscous digesta from β-glucans promotes conditions favorable to pathogenic bacteria, including Clostridium perfringens, the causative agent of necrotic enteritis in poultry.
By reducing digesta viscosity, β-glucanase contributes to a healthier gut environment, supporting the effectiveness of other gut health management strategies. This synergy with antibiotic reduction programs drives adoption in regions with strict antibiotic regulations.
3. Aquaculture Expansion
Global aquaculture production continues to expand to meet demand for seafood. Fish and shrimp, like terrestrial monogastrics, lack endogenous enzymes to degrade β-glucans in plant-based feed ingredients. As aquaculture diets incorporate increasing levels of plant proteins to replace fishmeal, β-glucanase becomes essential for maintaining nutrient utilization.
The aquaculture segment represents the fastest-growing application for feed enzymes, with β-glucanase playing a key role in enabling sustainable expansion of farmed seafood production.
Exclusive Industry Insight: The “Thermal Stability” Formulation Challenge
An exclusive analysis of feed enzyme applications reveals that thermal stability during feed processing represents the most significant technical challenge for β-glucanase products. Pelleted feeds are exposed to temperatures of 80-95°C during conditioning and pelleting—conditions that rapidly denature unprotected enzymes.
Leading manufacturers address this challenge through several approaches:
- Thermostable enzyme variants selected or engineered for heat tolerance
- Coating technologies that protect enzymes during processing
- Liquid application post-pelleting for products lacking thermal stability
- Granulation that embeds enzymes in protective matrices
Products achieving thermal stability sufficient for standard pelleting processes capture premium positions, simplifying feed mill operations and ensuring enzyme activity reaches the animal.
Type Segmentation: Acidic and Neutral Enzyme Variants
The segmentation by Acidic and Neutral β-glucanase reflects the pH requirements of different animal species and gastrointestinal compartments.
Acidic β-glucanases are active in the low-pH environment of the stomach and proximal small intestine. These enzymes are particularly relevant for swine and other species with significant gastric digestion. Stability at low pH is essential for activity before intestinal transit.
Neutral β-glucanases function optimally at the pH of the small intestine, where most nutrient absorption occurs. These enzymes may be preferred for poultry and species where crop and proventriculus provide limited exposure before intestinal delivery.
Many commercial products incorporate both acidic and neutral activities, ensuring activity throughout the gastrointestinal tract.
Application Segmentation: Poultry, Swine, and Aquaculture
The application segmentation—Poultry, Swine, Aquaculture, and Others—reveals distinct market characteristics and growth trajectories.
Poultry represents the largest current market segment, driven by the scale of global broiler production and the sensitivity of young birds to viscous grains. Broilers have short digestive tracts and rapid feed passage, making them particularly vulnerable to viscosity-mediated performance depression. β-glucanase responses in poultry are well-documented, supporting widespread adoption.
Swine applications benefit from β-glucanase in both nursery and grow-finish phases. Weaned pigs experience digestive challenges that make them responsive to enzyme addition; growing pigs benefit from improved energy utilization from cereal grains.
Aquaculture represents the fastest-growing segment, with applications in salmon, tilapia, shrimp, and other farmed species. The trend toward plant-based feeds in aquaculture creates sustained demand for enzymes enabling nutrient utilization.
Competitive Landscape: Global Enzyme Leaders and Regional Specialists
The competitive landscape spans global biotechnology leaders with comprehensive enzyme portfolios and specialized regional manufacturers.
Novozymes and DSM-Firmenich lead the global enzyme market with extensive research capabilities, broad product lines, and global distribution networks. Their scale enables investment in enzyme discovery, protein engineering, and application development.
AB Enzymes, BASF, and Kemin Industries offer competitive enzyme products with regional strength and application expertise.
Aum Enzymes, Creative Biogene, Guangdong Vtr Bio-Tech, Wuhan Sunhy Biology, Fuda Biotech, Sunson Industry Group, Beijing Strowin Biotechnology (BSB) , Shandong Sukahan Bio-Technology, and Qingdao Vland Biotech represent Chinese manufacturers with growing capabilities, cost-competitive production, and domestic market focus.
Value Chain Dynamics: From Strain Development to Finished Feed
The upstream value chain begins with microbial strain development—genetically engineered strains of Trichoderma reesei, Aspergillus niger, and other production organisms optimized for enzyme yield and specific activity. Fermentation raw materials, including carbon and nitrogen sources such as corn starch and soybean meal, are sourced from agricultural commodity markets.
The midstream comprises enzyme manufacturers conducting fermentation, recovery, formulation, and quality control. Downstream end-users are large-scale feed producers and integrated livestock operations, which incorporate enzyme products into premixes and complete feeds.
Conclusion
As the Feed β-Glucanase market approaches its US$75.2 million forecast in 2032, success will be defined by enzyme efficacy, thermal stability, and application-specific optimization. The 7.4% CAGR reflects increasing recognition that enzyme technologies enable more efficient, flexible, and sustainable animal production. For feed formulators and livestock producers, selecting β-glucanase products requires understanding enzyme characteristics, diet composition, and production system requirements. For enzyme manufacturers and investors, the sector offers steady growth with opportunities for value creation through novel enzyme variants, enhanced formulations, and expansion into aquaculture and other emerging applications. In an industry where feed represents 60-70% of production cost, enzymes that improve nutrient utilization deliver compelling economic value.
The Feed β-Glucanase market is segmented as below:
Key Players:
Novozymes, AB Enzymes, DSM-Firmenich, Aum Enzymes, BASF, Kemin Industries, Creative Biogene, Guangdong Vtr Bio-Tech, Wuhan Sunhy Biology, Fuda Biotech, Sunson Industry Group, Beijing Strowin Biotechnology (BSB), Shandong Sukahan Bio-Technology, Qingdao Vland Biotech
Segment by Type
- Acidic
- Neutral
Segment by Application
- Swine
- Poultry
- Aquaculture
- Others
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
